The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...

Several companies such as Shriram Finance, Symphony, etc. will be in focus today on account of corporate actions.

GlaxoSmithKline Pharmaceuticals and Sasken Technologies have released their financial results for the quarter that ended on ...

GlaxoSmithKline Pharmaceuticals Limited reported that its revenue from operations in the second quarter of FY25 crossed Rs 1000 crore, up 5 per cent Year-on-Year. Profit After Tax (PAT) for the ...

GlaxoSmithKline Pharmaceuticals on October 29 reported a 16 percent year-on-year increase in its consolidated net profit to Rs 252 crore in the September quarter, aided by robust sales across ...

GlaxoSmithKline Pharmaceuticals reported a notable 16% rise in consolidated net profit for the September quarter, reaching Rs 252 crore. This growth was driven by robust sales and brand performance.

GlaxoSmithKline Pharmaceuticals reports a 16% jump in Q2 net profit to Rs 252 crore, driven by strong sales across segments.

GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market ... low awareness, and limited eligible patient pools.

India's GlaxoSmithKline Pharmaceuticals reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand ...

L&T, Tata Power, New India Assurance and Aditya Birla Capital are some of the firms that will release their financial results ...